Under these regulations, a product is considered a medicinal product if: It is intended to treat or prevent disease
The researchers attributed those outcomes to retatrutide's triple agonist pharmacology and the downstream effects on weight, insulin sensitivity, and fat oxidation, not to what participants were eating
There is also an individual patient response
As with any type of medication, there are side effects and they should be taken under the direction of a healthcare provider
Even though the definitive role of GSH imbalance in PD is still debated, the efficacy of therapeutic antioxidant and anti-inflammatory agents in PD models underscores the potential of targeting this pathway to halt disease progression (Leathem et al., 2022)
PTDM, post-transplant diabetes mellitus